India has become a key market for global tech giants, with a burgeoning developer base attracting significant attention. Tim Cook, CEO of Apple, expressed his contentment with India's growing developer community, underlining Apple's holistic approach covering everything from developer support to market strategies and operational efficiency.
Eli Lilly and Company’s Tirzepatide GLP-1 Weight Loss Drug Is Now Poised To Shrink the Market for Breathing Machines
18.04.2024 - 03:25 / wccftech.com / Rohail Saleem
This is not investment advice. The author has no position in any of the stocks mentioned. Wccftech.com has a disclosure and ethics policy.
What if a single pharmaceutical intervention regime could not only sustainably shrink your waistline but also cure your Obstructive Sleep Apnea (OSA)? This seems too good to be true. Yet, Eli Lilly and Company's (NYSE: LLY) Tirzepatide GLP-1 drug seems to have achieved just that.
Eli Lilly and Company’s "Tirzepatide Led to a Mean AHI Reduction From Baseline of 62.8% Compared to 6.4% From Baseline for Placebo," as per the Results of the SURMOUNT-OSA Study 2.
To wit, Eli Lilly and Company has now announced the results of two studies that investigated the impact of its Tirzepatide GLP-1 offering on sleep apnea. As per the results of the second SURMOUNT-OSA study, Tirzepatide managed to reduce sleep apnea severity by around two-thirds in adults with OSA.
Related Story Novo Nordisk’s GLP-1 Weight Loss Drug Wegovy Is Not a Panacea for Obesity
As a refresher, the GLP-1 hormone plays an important role in suppressing hunger and regulating the production of insulin and glucose. After a meal, GLP-1 agonists raise the level of insulin, which decreases blood glucose levels. Simultaneously, these drugs reduce the speed at which the stomach empties its contents into the small intestine, thereby increasing the feeling of fullness and satiation.
Eli Lilly and Company now plans to submit these results to the US FDA, which is expected to significantly improve Tirzepatide's prospects of securing the US government's insurance coverage for OSA treatment.
Currently, Eli Lilly and Company offers Tirzepatide as one of its proprietary injections-based drugs to combat diabetes and obesity, leveraging both GLP-1 and Glucose-dependent Insulinotropic Polypeptide (GIP) agonists to offer better efficacy. The company markets Tirzepatide under the Mounjaro and Zepbound labels, with the former geared toward diabetes and the latter billed as a treatment for obesity.
Today's announcement is all the more important as OSA currently has no approved treatment except ResMed's continuous Positive Airway Pressure (PAP) therapy devices, which can alleviate the symptoms of sleep apnea. Consequently, analysts now believe that Tirzepatide's entry as a viable treatment can shrink the market for these breathing devices by over 11 percent in the next few years.
The website gametalkz.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
Top Authors
Popular Topics
wccftech.com
02.05.2024 / 16:11
Trump Media and Technology Group (DJT) Writes a Second Letter to the Relevant Committees of the US Congress To Urge Investigation Into the “Potential Manipulation” of Its Stock
This is not investment advice. The author has no position in any of the stocks mentioned. Wccftech.com has a disclosure and ethics policy.
gamesindustry.biz
30.04.2024 / 12:45
How Sonic Mania paved the way for Penny's Big Breakaway
It's been a fascinating journey for the developers behind indie game studio Evening Star. Much of the crew got their humble starts working together on Sonic the Hedgehog fan games. Their work was so highly regarded that they would eventually be recruited by Sega to develop Sonic Mania, a throwback to the franchise's 2D heyday that would go on to become the highest rated Sonic game in over 25 years.
wccftech.com
26.04.2024 / 18:19
Intel’s Embrace of High-NA EUV Lithography and TSMC’s Reluctance Threatens to Flip the Prevailing Industry Supremacy Paradigm
This is not investment advice. The author has no position in any of the stocks mentioned. Wccftech.com has a disclosure and ethics policy.
ign.com
26.04.2024 / 15:09
Elden Ring Players Who Really Hated Malenia Can Now Buy Her Detached Arm for Almost $400
Elden Ring fans rejoice, for you can now preorder a limited run, life-size replica of the demigod Malenia’s golden prosthetic right arm, courtesy of a partnership between publisher Bandai Namco, and collectibles distributor PureArts Studio.
polygon.com
24.04.2024 / 16:09
Fallout is ‘probably the best-performing Commander set ever,’ says Hasbro CEO
Magic: The Gathering’s recent set of Fallout-themed cards is the franchise’s “best-performing Commander set ever” said Hasbro CEO Chris Cocks. The announcement, made Wednesday during an earnings call with investors, brings attention to the potential of the trading card games’ ambitious Universes Beyond initiative. But it also highlights the risks of working with IP licensed from other companies.
tech.hindustantimes.com
24.04.2024 / 10:37
Top 10 smartwatch brands: Leading the market with innovation
Modern smartwatches are more than simply an accessory, with complex capabilities like voice assistants, crash detection, call and text compatibility, and long battery lives. They've also become one of the most popular health and fitness trackers, thanks to sophisticated sensors and large app suites. Smartwatches are very useful and one of the most convenient gadgets for tracking your fitness and health activity, such as heart rate, oxygen level, sleep monitoring, steps and distance covered, calories burned,women's health monitoring and so on, and they also include emergency aid.
videogameschronicle.com
23.04.2024 / 23:57
Embracer CEO suggests he must shoulder much of the blame for a ‘long list’ of mistakes
Embracer Group CEO Lars Wingefors has suggested he must shoulder much of the blame for a “long list” of mistakes that led to a “painful” restructuring of the company.
rockpapershotgun.com
23.04.2024 / 13:15
Arise now, ye Cerim: No Rest for the Wicked’s performance updates are underway
No Rest for the Wicked launched into early access as a bit of a fixer-upper, even by the standards of its 'buy now, play finished game later' model. The good news is that the grim action-RPG’s wonky performance is already being straightened out, with two of its three hotfixes thus far delivering a noticeable improvements, even on older graphics cards.
gadgets.ndtv.com
23.04.2024 / 08:34
'Lord of the Rings' Owner Embracer Group Announces Plan to Split Into 3 Standalone Companies: Details
Embracer Group, the embattled gaming conglomerate that owns the rights to 'The Lord of the Rings' franchise, has announced that it is splitting into three different companies. The group, which went through significant restructuring this year and sold off major game studios like Saber Interactive and Gearbox to reduce debt, will separate into Asmodee Group, Coffee Stain & Friends, and Middle-earth Enterprises & Friends. The three games and entertainment companies will be standalone, publicly listed entities, Embracer said, with the split “enabling each entity to better focus on their respective core strategies and offer more differentiated and distinct equity stories for existing and new shareholders.”
wccftech.com
21.04.2024 / 09:57
Fourth Bitcoin Halving Officially Arrives With Expectations of at Least 200 Percent Gains Within the Next 18 Months
This is not investment advice. The author has no position in any of the stocks mentioned. Wccftech.com has a disclosure and ethics policy.
eurogamer.net
21.04.2024 / 07:03
Ark's animated series now streaming in the UK and 10 other territories
If you've been eager to watch the animated Ark: Survival Evolved TV series, but your attempts have so far been thwarted by your failure to live in the US or Canada, there's some good news: it's now officially available in 11 other countries, including the UK, via Paramount+.